HIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include all the... |
Did you find an answer to your question?
Yes
No
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Our medical information is accurate, up to date, and scientifically balanced.
HALCION®, CIV (triazolam)
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
Our medical information is accurate, up to date, and scientifically balanced.
HALCION®, CIV Quick Finder
Highlights
Boxed Warning
WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS; ABUSE, MISUSE, AND ADDICTION; and DEPENDENCE AND WITHDRAWAL REACTIONS
- •
- Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma,...
Did you find an answer to your question?
Yes
No
Indications and Usage
1 INDICATIONS AND USAGE
Halcion is indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults.
Did you find an answer to your question?
Yes
No
Dosage and Administration
2 DOSAGE AND ADMINISTRATION
2.1 Dosing Information
The recommended dosage is 0.25 mg once daily before bedtime. A dosage of 0.125 mg once daily may be sufficient for...
Did you find an answer to your question?
Yes
No
Dosage Forms and Strengths
3 DOSAGE FORMS AND STRENGTHS
Halcion is available as 0.25 mg tablets. The tablets are powder blue, elliptical, scored, and imprinted with HALCION 0.25.
Did you find an answer to your question?
Yes
No
Contraindications
4 CONTRAINDICATIONS
Halcion is contraindicated in:
- •
- Patients with known hypersensitivity to triazolam, any of component of Halcion, or other benzodiazepines. Reactions consistent with angioedema (...
Did you find an answer to your question?
Yes
No
Warnings and Precautions
5 WARNINGS AND PRECAUTIONS
5.1 Risks From Concomitant Use With Opioids
Concomitant use of benzodiazepines, including Halcion, and opioids may result in profound...
Did you find an answer to your question?
Yes
No
Adverse Reactions
6 ADVERSE REACTIONS
The following serious adverse reactions are discussed in greater detail in other sections:
- •
- Risks from Concomitant Use with Opioids [see Warnings...
Did you find an answer to your question?
Yes
No
Drug Interactions
7 DRUG INTERACTIONS
7.1 Drugs Having Clinically Important Interactions With Halcion
Table 2 includes clinically significant drug interactions with Halcion...
Did you find an answer to your question?
Yes
No
Use in Specific Populations
8 USE IN SPECIFIC POPULATIONS
8.1 Pregnancy
Pregnancy Exposure Registry
There...
Did you find an answer to your question?
Yes
No
Drug Abuse and Dependence
...
9 DRUG ABUSE AND DEPENDENCE
9.1 Controlled Substance
Halcion contains triazolam, a Schedule IV controlled substance.
Did you find an answer to your question?
Yes
No
Overdosage
10 OVERDOSAGE
Overdosage of benzodiazepines is characterized by central nervous system depression ranging from drowsiness to coma. In mild to moderate cases, symptoms can include drowsiness, confusion, dysarthria, lethargy,...
Did you find an answer to your question?
Yes
No
Description
11 DESCRIPTION
Halcion Tablets contains triazolam, a triazolobenzodiazepine.
Triazolam is a white crystalline powder, soluble in alcohol and poorly soluble in water. It has a molecular weight of 343.21.
The...
Did you find an answer to your question?
Yes
No
Clinical Pharmacology
12 CLINICAL PHARMACOLOGY
12.1 Mechanism of Action
Triazolam is a benzodiazepine. Triazolam exerts its effect for the short-term treatment of insomnia through binding...
Did you find an answer to your question?
Yes
No
Nonclinical Toxicology
13 NONCLINICAL TOXICOLOGY
13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility
...
Did you find an answer to your question?
Yes
No
How Supplied/Storage and Handling
16 HOW SUPPLIED/STORAGE AND HANDLING
Halcion is supplied as a powder blue, elliptical, scored tablet in the following strengths and package configurations:
Did you find an answer to your question?
Yes
No
Other
This product's labeling may have been updated. For the most recent prescribing information, please visit www.pfizer.com.
...
Did you find an answer to your question?
Yes
No
Did you find an answer to your question?
Yes
No
Didn’t find what you were looking for? Contact us.
To interact with the Medical Information Digital Assistant click here.
Contact Pfizer Medical Information to speak with a professional regarding your medical question on a Pfizer prescription product: (800) 438-1985
Report Adverse Event
To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at(800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatchor by calling
(800)-332-1088.
(800)-332-1088.